Search

Your search keyword '"Adenocarcinoma, Bronchiolo-Alveolar drug therapy"' showing total 4 results
Start Over Descriptor "Adenocarcinoma, Bronchiolo-Alveolar drug therapy" Language german
4 results on '"Adenocarcinoma, Bronchiolo-Alveolar drug therapy"'

1. [Therapy of inoperable bronchial carcinoma].

Author

Kokron O, Cerni C, Micksche M, Titscher R, and Wrba H

Subjects
Adenocarcinoma drug therapy, Adenocarcinoma, Bronchiolo-Alveolar drug therapy, Adult, Aged, Antigens, Neoplasm administration & dosage, Antineoplastic Agents therapeutic use, Bronchial Neoplasms immunology, Carcinoma drug therapy, Carcinoma, Squamous Cell drug therapy, Drug Therapy, Combination, Female, Humans, Lung Neoplasms drug therapy, Male, Middle Aged, Neoplasm Metastasis, Prognosis, Vitamin A therapeutic use, Bronchial Neoplasms drug therapy
Abstract

The results of a prospective randomized study on carcinoma of the bronchus are reported. In a total of 56 patients polychemotherapy, high-dosage vitamin-A treatment, Endoxan and immunotherapy, as well as the application of proteolytic enzymes in altogether 5 combinations of therapy were tested.

Published
1977

2. [Three years of experience in the polychemotherapy of inoperable bronchial carcinoma].

Author

Wrbka E

Subjects
Adenocarcinoma mortality, Adenocarcinoma, Bronchiolo-Alveolar mortality, Adult, Aged, Austria, Bronchial Neoplasms mortality, Carcinoma, Squamous Cell mortality, Cyclophosphamide therapeutic use, Drug Therapy, Combination, Female, Fluorouracil therapeutic use, Humans, Long-Term Care, Male, Methotrexate therapeutic use, Middle Aged, Palliative Care, Time Factors, Vinblastine therapeutic use, Adenocarcinoma drug therapy, Adenocarcinoma, Bronchiolo-Alveolar drug therapy, Antineoplastic Agents therapeutic use, Bronchial Neoplasms drug therapy, Carcinoma, Squamous Cell drug therapy
Published
1974

3. [Dacarbacinum (DTIC) and bronchogenic carcinoma (author's transl)].

Author

Titscher R

Subjects
Adenocarcinoma, Bronchiolo-Alveolar drug therapy, Aged, Carcinoma drug therapy, Carcinoma, Small Cell drug therapy, Drug Evaluation, Drug Therapy, Combination, Female, Humans, Lung Neoplasms surgery, Male, Middle Aged, Pneumonectomy, Vitamin A administration & dosage, Vitamin A therapeutic use, Dacarbazine therapeutic use, Lung Neoplasms drug therapy, Triazenes therapeutic use
Abstract

A pilot study is reported on the results achieved with the cytostatic agent dacarbacinum (DTIC) on previously untreated, inoperable bronchogenic carcinomas which had been histologically and/or cytologically verified. Altogether there were 16 patients, i.e. 13 males and 3 females. DTIC monotherapy was administered to 14 patients; one patient received additionally vitamin A in high dosage and a further patient VP 16 (a podophyllotoxin preparation). The achieved results (a remission rate of 50%) justify the further application of this agent, whereby its relatively limited side effects as well as goood tolerability in elderly patients (over 70 years of age) are emphasized. The inclusion of the preparation in effective combinations is discussed.

Published
1978

Catalog

Books, media, physical & digital resources
See catalog results